Dr. Menon is a co-founder of Innovation, serving as Chief Scientific Officer, and Board Member. He is a leading pharmaceutical scientist with over 30 years of drug development experience in academia and industry. Prior to Innovation, Dr. Menon served at Eli Lilly as Group Leader, Cancer In Vivo Research and Clinical Development. While there, Dr. Menon played an integral role in lead selection and pre-clinical development of Gemzar and Alimta, two blockbuster oncology drugs. He was awarded Eli Lilly’s prestigious President’s Recognition Award. Earlier in his professional career, he held research scientist positions at Miles Laboratories and Dana Farber Cancer Research Institute. Dr. Menon is a trained veterinary surgeon (DVM) and holds a PhD (Pharmacology) from Kerala University.    

 Dr. Menon is a co-founder of Innovation, serving as Chief Scientific Officer, and Board Member. He is a leading pharmaceutical scientist with over 30 years of drug development experience in academia and industry. Prior to Innovation, Dr. Menon served at Eli Lilly as Group Leader, Cancer In Vivo Research and Clinical Development. While there, Dr. Menon played an integral role in lead selection and pre-clinical development of Gemzar and Alimta, two blockbuster oncology drugs. He was awarded Eli Lilly’s prestigious President’s Recognition Award. Earlier in his professional career, he held research scientist positions at Miles Laboratories and Dana Farber Cancer Research Institute. Dr. Menon is a trained veterinary surgeon (DVM) and holds a PhD (Pharmacology) from Kerala University.